What is the appropriate treatment for a Candida glabrata urinary tract infection in a patient taking clopidogrel (Plavix)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Treatment of Candida glabrata UTI in Patients on Plavix

For fluconazole-resistant C. glabrata UTI, treat with amphotericin B deoxycholate 0.3–0.6 mg/kg daily for 1–7 days OR oral flucytosine 25 mg/kg four times daily for 7–10 days, and remove the indwelling bladder catheter if present—Plavix does not contraindicate these antifungal agents and should be continued for cardiovascular protection. 1

Key Treatment Algorithm

Step 1: Determine if Treatment is Necessary

  • Most candiduria represents colonization and does NOT require treatment unless the patient is:
    • Neutropenic
    • Very low birth weight infant (<1500g)
    • Undergoing urologic manipulation
    • Symptomatic with cystitis or pyelonephritis 1

Step 2: Remove Predisposing Factors

  • Remove indwelling bladder catheter if feasible (strong recommendation) 1
  • This alone clears candiduria in approximately 50% of asymptomatic patients 2

Step 3: Obtain Susceptibility Testing

C. glabrata has variable fluconazole susceptibility—you must know if the isolate is fluconazole-susceptible or resistant before selecting therapy.

Step 4: Select Antifungal Based on Susceptibility

For Fluconazole-SUSCEPTIBLE C. glabrata:

  • Cystitis: Oral fluconazole 200 mg (3 mg/kg) daily for 2 weeks 1
  • Pyelonephritis: Oral fluconazole 200–400 mg (3–6 mg/kg) daily for 2 weeks 1

For Fluconazole-RESISTANT C. glabrata (most common scenario):

  • Cystitis:

    • Amphotericin B deoxycholate 0.3–0.6 mg/kg IV daily for 1–7 days, OR
    • Oral flucytosine 25 mg/kg four times daily for 7–10 days 1

  • Pyelonephritis:

    • Amphotericin B deoxycholate 0.3–0.6 mg/kg IV daily for 1–7 days with or without oral flucytosine 25 mg/kg four times daily 1
    • Alternative: Flucytosine monotherapy 25 mg/kg four times daily for 2 weeks (weaker recommendation) 1

The Plavix Question: No Drug Interaction Concerns

There are NO clinically significant drug interactions between clopidogrel (Plavix) and the recommended antifungals for C. glabrata UTI. The Plavix label does not list amphotericin B, flucytosine, or fluconazole as contraindicated medications 3.

Critical Caveat About Azoles

  • The Plavix label specifically warns against omeprazole and esomeprazole (proton pump inhibitors), which reduce clopidogrel's antiplatelet activity 3
  • Fluconazole is NOT mentioned as problematic in the Plavix drug label
  • However, fluconazole is often ineffective against C. glabrata anyway, making this a moot point in most cases

Why Plavix Should NOT Be Stopped

Do not discontinue Plavix without consulting the prescribing cardiologist. The drug label explicitly warns that premature discontinuation increases the risk of:

  • Myocardial infarction
  • Cardiovascular death
  • Stroke 3

Patients on Plavix typically have recent ACS, stroke, or peripheral arterial disease—stopping antiplatelet therapy for a UTI would be inappropriate risk-benefit analysis.

Why Echinocandins Are NOT Recommended

Despite case reports of successful micafungin treatment 4, 5, echinocandins achieve negligible urinary concentrations and are not recommended by IDSA guidelines for UTI treatment 2, 6, 7. The guidelines are clear: fluconazole, amphotericin B, and flucytosine are the only appropriate systemic agents because they achieve adequate urinary levels.

Common Pitfalls to Avoid

  1. Treating asymptomatic candiduria unnecessarily: Most patients are colonized, not infected 1, 7

  2. Using echinocandins for UTI: They don't achieve therapeutic urine concentrations despite occasional case report successes 2, 6

  3. Assuming all C. glabrata is fluconazole-resistant: Always check susceptibilities—some isolates remain susceptible 1

  4. Stopping Plavix for antifungal therapy: No interaction exists, and stopping increases cardiovascular risk 3

  5. Bladder irrigation as primary therapy: AmB bladder irrigation (50 mg/L sterile water daily for 5 days) is only a weak recommendation for fluconazole-resistant cystitis and should not replace systemic therapy 1

Monitoring Considerations

  • Flucytosine requires monitoring for bone marrow suppression and hepatotoxicity—check CBC and liver function tests 1
  • Amphotericin B requires monitoring for nephrotoxicity and electrolyte abnormalities—check creatinine, potassium, and magnesium 1
  • Plavix increases bleeding risk, which may be relevant if invasive urologic procedures are needed, but does not contraindicate antifungal therapy 3

References

2
Research

Candida urinary tract infections: treatment options.

Expert review of anti-infective therapy, 2007

4
Research

Treatment of candiduria with micafungin: A case series.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2007

5
Research

Unilateral renal fungus ball caused by Candida glabrata.

Medical mycology case reports, 2024

7
Research

Candida urinary tract infections--treatment.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011

Related Questions

What is the recommended management for a 44-year-old female with a Candida albicans urine culture of 10,000–<50,000 CFU, pyuria on urinalysis, and dysuria?
How should a Candida urinary tract infection be treated in a non‑pregnant adult with normal renal function?
How should a urinary tract infection caused by Candida glabrata be treated?
What is the antifungal of choice for a diabetic patient with a Candida urinary tract infection showing 20–30 pus cells per high‑power field?
In a 54-year-old woman presenting with initial urinary tract infection symptoms and a urine culture growing 3,000 colony‑forming units per milliliter yeast, should she be treated for candiduria or for a typical bacterial urinary tract infection?
For what indications is propranolol FDA approved?
How effective is low‑dose doxepin compared with zolpidem (Ambien) for treating insomnia characterized by difficulty maintaining sleep after initial sleep onset?
Should a patient presenting with a hypertensive emergency that requires intravenous antihypertensive infusion and continuous arterial blood pressure monitoring be admitted to the intensive care unit or to a regular floor?
Can I discharge a patient who presents only anxiety symptoms and prescribe the herbal product Seakalm, despite his severe hypertension (blood pressure 160/120 mmHg) and absence of acute target‑organ damage?
What are the maximum daily doses of haloperidol (Haldol) and bupropion (Wellbutrin) that can be safely co‑administered in an adult without cardiac disease or seizure disorder?
What is the proper technique and dosage for injecting a small dose of bupivacaine into a tender trigger point in the trapezius muscle?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.